There are still seats available for the upcoming Preceptorship ‘New developments in specific risk groups of Acute Lymphoblastic Leukemia’ on May 19 & 20, 2025 in Utrecht in The Netherlands.
The Preceptorship is a highly practical and interactive live forum, organized by the Princess Máxima Center for Pediatric Oncology (Utrecht, The Netherlands), the comprehensive childhood cancer center of excellence, centralizing all Dutch patients in one center. The Preceptorship has a limited number of participants to enable more interaction.
It provides a unique opportunity for (pediatric) oncologists and hematologists (whether or not in training) or other experts in the field to interact with leading Dutch and international faculty in order to increase clinical knowledge, apply new data to practice, and ultimately improve patient outcomes. Main topics will focus on new developments for specific patient populations, new treatment strategies for specific molecular and immunological sub-groups and approaches to reduce toxicity.
For registration and more information about the program we refer to the event website.
The Preceptorship meeting is accredited by the EACCME® for CME.